Indeed, a therapeutic combination currently utilized for the treatment of AD involves the administration of both donepezil, an acetylcholinesterase (AChE) inhibitor, and memantine, an NMDA receptor antagonist. This evidence concerns the gene ACHE and Alzheimer disease.